Condition

Diabetes

1 approval (1 source record) from January 1, 2025 through October 16, 2026. Data pulled October 16, 2026.

August 2025

Health Canada

TEPLIZUMAB 2 MG

Company: SANOFI-AVENTIS CANADA INC

Original market date: August 20, 2025

Data pulled: October 16, 2026

Condition mapped from Health Canada ATC A10XX01 TEPLIZUMAB.